- Home
- KTCC vs FGEN Comparison
KTCC vs FGEN Comparison
Compare KTCC & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- FGEN
- Stock Information
- Founded
- KTCC 1969
- FGEN 1993
- Country
- KTCC United States
- FGEN United States
- Employees
- KTCC N/A
- FGEN N/A
- Industry
- KTCC Electrical Products
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- FGEN Health Care
- Exchange
- KTCC Nasdaq
- FGEN Nasdaq
- Market Cap
- KTCC 34.0M
- FGEN 33.5M
- IPO Year
- KTCC N/A
- FGEN 2014
- Fundamental
- Price
- KTCC $2.30
- FGEN $0.27
- Analyst Decision
- KTCC
- FGEN Strong Buy
- Analyst Count
- KTCC 0
- FGEN 1
- Target Price
- KTCC N/A
- FGEN $10.00
- AVG Volume (30 Days)
- KTCC 27.6K
- FGEN 1.5M
- Earning Date
- KTCC 05-06-2025
- FGEN 05-05-2025
- Dividend Yield
- KTCC N/A
- FGEN N/A
- EPS Growth
- KTCC N/A
- FGEN N/A
- EPS
- KTCC N/A
- FGEN N/A
- Revenue
- KTCC $514,394,000.00
- FGEN $29,621,000.00
- Revenue This Year
- KTCC N/A
- FGEN $544.98
- Revenue Next Year
- KTCC N/A
- FGEN $9.45
- P/E Ratio
- KTCC N/A
- FGEN N/A
- Revenue Growth
- KTCC N/A
- FGEN N/A
- 52 Week Low
- KTCC $2.25
- FGEN $0.18
- 52 Week High
- KTCC $6.14
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- KTCC 29.20
- FGEN 32.23
- Support Level
- KTCC $2.38
- FGEN $0.28
- Resistance Level
- KTCC $2.70
- FGEN $0.32
- Average True Range (ATR)
- KTCC 0.10
- FGEN 0.03
- MACD
- KTCC 0.01
- FGEN -0.00
- Stochastic Oscillator
- KTCC 8.33
- FGEN 1.27
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.